Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 27, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

Predictive models for anti-tubercular molecules using machine learning on high-throughput biological screening

Vinita Periwal1, Jinuraj K Rajappan,

  • 1GN Ramachandran Knowledge Center for Genome Informatics, CSIR Institute of Genomics and Integrative Biology (CSIR-IGIB), Mall Road, Delhi - 110007, India. jaleel.uc@gmail.com.

BMC Research Notes
|November 22, 2011
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Common xenobiotics modulate gut microbial responses to low‑calorie sweeteners in vitro.

Molecular systems biology·2026
Same author

Geographic boundary for the Asian-type DEL in south Asia.

iScience·2026
Same author

Subtle Clinical Clues for Early Diagnosis of Lethal ORAI1 Deficiency in Infants.

Indian journal of pediatrics·2026
Same author

Addressing pandemic-wide systematic errors in the SARS-CoV-2 phylogeny.

Nature methods·2026
Same author

Germline mutational landscape in a large cohort of Indian breast cancer.

BMC cancer·2025
Same author

Identification and Functional Validation of Novel Pathogenic Variants in Primary Immunodeficiencies.

European journal of immunology·2025

This study developed machine learning models to predict tuberculosis drug candidates, addressing the urgent need for new treatments against drug-resistant Mycobacterium tuberculosis strains. These computational approaches accelerate the identification of potential anti-tubercular agents.

Area of Science:

  • Computational chemistry
  • Machine learning
  • Drug discovery

Background:

  • Tuberculosis (TB) is a global health crisis caused by Mycobacterium tuberculosis (Mtb), with rising drug resistance necessitating novel therapeutic strategies.
  • Multi-drug resistant (MDR) and extensively drug-resistant (XDR) Mtb strains pose a significant threat, demanding faster lead identification methods.
  • Traditional drug discovery methods like target-based screening are limited by target structure knowledge, while whole organism screens are time-consuming and costly.

Purpose of the Study:

  • To develop computational approaches for prioritizing molecules in anti-tubercular drug discovery programs.
  • To create target-agnostic predictive models for identifying novel anti-tubercular agents.
  • To leverage machine learning for efficient lead identification in the face of drug-resistant tuberculosis.

More Related Videos

Assay Development for High-Throughput Drug Screening Against Mycobacteria
07:50

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

Related Experiment Videos

Last Updated: May 27, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

Assay Development for High-Throughput Drug Screening Against Mycobacteria
07:50

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

Main Methods:

  • Utilized physicochemical properties of compounds to train supervised machine learning classifiers.
  • Employed four classifiers: Naïve Bayes, Random Forest, J48, and SMO.
  • Validated predictive model robustness using statistical measures on publicly available bioassay data for Mtb inhibitors.

Main Results:

  • Successfully trained and validated machine learning models capable of predicting anti-tubercular activity.
  • Demonstrated the utility of physicochemical properties in building predictive models for Mtb inhibitors.
  • Established robust, target-agnostic predictive models for anti-tubercular agents.

Conclusions:

  • This study provides a comprehensive analysis of high-throughput bioassay data for anti-tubercular activity.
  • Machine learning approaches are effective in creating target-agnostic predictive models for anti-tubercular agents.
  • The developed models can accelerate the identification of novel drug leads to combat drug-resistant tuberculosis.